# AUTOANTIBODIES AND SYSTEMIC SCLEROSIS

> **NCT06502678** · — · NOT_YET_RECRUITING · sponsor: **IRCCS Ospedale San Raffaele** · enrollment: 6 (estimated)

## Conditions studied

- Understand Pathogenicity of SSc-specific Antibodies in SSc and the Effect of Antibody Blockade in Vitro

## Interventions

- **BIOLOGICAL:** Fcr blocker of autoantibodies

## Key facts

- **NCT ID:** NCT06502678
- **Lead sponsor:** IRCCS Ospedale San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06502678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06502678, "AUTOANTIBODIES AND SYSTEMIC SCLEROSIS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06502678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*